AmSurg

AmSurg is a healthcare services company headquartered in Nashville, Tennessee, that specializes in ambulatory surgery center operations and management. Founded in 1992, AmSurg grew into one of the largest operators of outpatient surgical facilities in the United States. The company's history spans a public listing on NASDAQ, acquisition by Envision Healthcare in 2016, a Chapter 11 bankruptcy restructuring in 2023, and a pending $3.9 billion acquisition by Ascension Health announced in 2025. AmSurg's business model focuses on acquiring, developing, and operating ambulatory surgery centers across multiple surgical specialties, representing a significant shift in how outpatient surgical care is delivered in the American healthcare system.

History

AmSurg was founded in 1992 in Nashville, Tennessee, with a focus on acquiring and operating ambulatory surgery centers. The company started by purchasing small groups of facilities, primarily in the Southeast, then expanded nationally. During the early 2000s, AmSurg became one of the first companies to apply a scalable, multi-specialty model to ASC management, which set it apart from competitors who typically focused on single-specialty centers. The company listed on the NASDAQ stock exchange under the ticker symbol "AMSG," giving it the capital needed for rapid expansion through acquisitions.

Throughout the 2010s, AmSurg executed an aggressive acquisition strategy, purchasing hundreds of ambulatory surgery centers and surgical practices across the United States. Growth came from a broader industry shift toward moving outpatient procedures from hospital settings to lower-cost ambulatory facilities, which offered cost savings for healthcare systems and operational efficiencies for surgical practices. In 2016, Envision Healthcare Corporation merged with AmSurg in a transaction that created a larger integrated healthcare services company. The deal consolidated AmSurg's surgery center network under Envision's broader portfolio of physician staffing and emergency medicine services. AmSurg continued to operate as a distinct business unit within Envision, maintaining its Nashville headquarters and managing surgical facilities under the AmSurg brand.

Bankruptcy and Restructuring

Envision Healthcare filed for Chapter 11 bankruptcy protection in May 2023, weighed down by debt accumulated through its private equity ownership under KKR and ongoing reimbursement disputes with insurers, most notably UnitedHealth Group. AmSurg was included in the bankruptcy filing as part of Envision's corporate structure. The company emerged from bankruptcy later in 2023, shedding a significant portion of its debt load and restructuring its operations. That process separated AmSurg's surgery center business from Envision's physician staffing operations, setting the stage for AmSurg to pursue an independent strategic path.

In 2025, Ascension Health announced its intent to acquire AmSurg for approximately $3.9 billion. The deal reflects Ascension's strategy to expand its outpatient care capacity and capture patient volume shifting away from expensive hospital settings. It's one of the largest transactions in the ambulatory surgery center sector in recent years. Ascension views AmSurg's national network of surgery centers as central to building a scaled outpatient platform that complements its existing hospital and clinical operations.

Economy

AmSurg's business model represented a significant innovation in healthcare economics and the operational structure of surgical services in the United States. The company's core strategy was to identify independently operated ambulatory surgery centers, acquire them, and apply standardized management practices, procurement strategies, and operational efficiencies that reduced costs and improved profitability. By consolidating purchasing power across hundreds of facilities, AmSurg negotiated better rates with pharmaceutical suppliers, equipment manufacturers, and service providers, generating economies of scale that individual surgery centers couldn't access on their own. This allowed AmSurg to maintain competitive reimbursement rates while improving margins, creating financial incentives for surgical practices and hospitals to partner with the company.

AmSurg's economic impact on Nashville's healthcare sector went beyond its direct operations. The company's headquarters attracted significant employment, with corporate staff supporting the management and growth of its national network of surgical facilities. AmSurg helped establish Nashville as a center for healthcare services administration, alongside the city's existing roles in healthcare education, medical publishing, and pharmaceutical services. The company's acquisition activity also drew investment capital and professional services firms to the Nashville area.

The broader economic case for ambulatory surgery centers, which AmSurg helped demonstrate at scale, rests on cost differentials between outpatient and inpatient settings. Procedures performed in ASCs consistently cost payers and patients less than the same procedures performed in hospital outpatient departments, without meaningful differences in clinical outcomes. That cost advantage accelerated industry consolidation throughout the 2010s and remains the primary driver behind Ascension's $3.9 billion bet on AmSurg's network.

Recognition

In 2026, U.S. News and World Report recognized 87 AmSurg surgery centers on its Best Ambulatory Surgery Centers list. The designation reflects performance across clinical quality, patient safety, and procedural outcomes. It's one of the most widely cited quality benchmarks in the outpatient surgical sector, and AmSurg's representation across 87 facilities placed it among the most recognized ASC operators in the country.

Notable People

Several executives shaped AmSurg's development over its three decades of operation. Early leadership established the company's acquisition-focused strategy and built its initial network of facilities in the Southeast before expanding nationally. Christopher A. Holden served as a senior executive and was responsible for managing the company's financial strategy through its growth phase and subsequent transactions. Board members included healthcare industry veterans, investors, and business leaders who provided oversight during the company's transitions from public company to Envision subsidiary to post-bankruptcy standalone operator.

When Envision filed for bankruptcy in 2023, leadership at AmSurg navigated a complex restructuring process that ultimately preserved the surgery center business as a going concern. That outcome made the Ascension acquisition possible. Key executives continued in operational roles through the restructuring, maintaining continuity across AmSurg's facility network during a period of significant financial and organizational change.

Notable Facilities and Reach

AmSurg's network of ambulatory surgery centers spans multiple surgical specialties, including orthopedics, general surgery, gastroenterology, ophthalmology, otolaryngology, and pain management. The company operates facilities in major metropolitan areas and regional markets across the United States, with significant concentrations in the Southeast, Southwest, and Mid-Atlantic regions. Major healthcare markets including Texas, Florida, California, and the Carolinas host AmSurg facilities, though the network covers more than 30 states. In December 2025, AmSurg announced its entry into the central Pennsylvania market through a new acquisition, showing continued expansion activity even during its post-bankruptcy period.

Each facility is equipped with operating rooms, recovery areas, and ancillary services necessary to provide comprehensive surgical care in an outpatient setting. AmSurg's multi-specialty approach differentiates it from traditional single-specialty ASCs, allowing for operational efficiencies and more diverse revenue streams. Standardization of quality, safety, and operational protocols across the network is a hallmark of the company's management approach, ensuring consistency in patient care and financial performance regardless of location or specialty focus.

Facilities operate under state and federal regulations governing outpatient surgical centers, including licensing requirements, accreditation standards, and reimbursement rules. AmSurg has invested in quality improvement initiatives and compliance programs to maintain patient safety standards across its network. The growth of AmSurg's facilities contributed to the broader trend of moving surgical procedures from inpatient hospital settings to lower-cost outpatient facilities, generating savings for payers and patients while maintaining clinical outcomes. With 87 centers earning U.S. News recognition in 2026 and a $3.9 billion acquisition pending, AmSurg's operational reach and clinical profile remain substantial.